Skip to main content Accessibility help

Variable expression of molecular markers in juvenile nasopharyngeal angiofibroma

  • A Mishra (a1), A Pandey (a2) and S C Mishra (a3)



Molecular categorisation may explain the wide variation in the clinical characteristics of juvenile nasopharyngeal angiofibroma.


Variations in molecular markers in juvenile nasopharyngeal angiofibroma in an Indian population were investigated and compared with global reports.


Variable molecular marker expression was demonstrated at the regional and global levels. A wide variation in molecular characteristics is evident. Molecular data have been reported for only 11 countries, indicating a clear geographical bias. Only 58 markers have been studied, and most are yet to be validated.


Research into the molecular epidemiology of juvenile nasopharyngeal angiofibroma is still in its infancy. Although the molecular variation is not well understood, data obtained so far have prompted important research questions. Hence, multicentre collaborative molecular studies are needed to establish the aetiopathogenesis and establish molecular surrogates for clinical characteristics.


Corresponding author

Address for correspondence: Dr A Mishra, A-1/19, Sector H Aliganj, Lucknow, Uttar Pradesh, India E-mail:


Hide All

This review is based PhD work of Dr Anupam Mishra.



Hide All
1 Mishra, A, Mishra, SC. Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George's Medical University, Lucknow India. J Laryngol Otol 2016;130:363–8
2 Chew, CT. Nasopharynx (the postnasal space). In: Kerr, AG, Groves, J, eds. Scott-Brown's Otolaryngology: Rhinology V. 4, 5th edn. London: Butterworth, 1987
3 Pandey, P, Mishra, A, Tripathi, AM, Verma, V, Trivedi, R, Singh, HP et al. Current molecular profile of juvenile nasopharyngeal angiofibroma: first comprehensive study from India. Laryngoscope 2016;3:E1006
4 Mishra, A, Singh, V, Verma, V, Pandey, S, Trivedi, R, Singh, HP et al. Current status and clinical correlation of beta-catenin in juvenile nasopharyngeal Angiofibroma. J Laryngol Otol 2016;30:17
5 Boghani, Z, Husain, Q, Kanumuri, VV, Khan, MN, Sangvhi, S, Liu, JK et al. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope 2013;123:859–69
6 Saylam, G, Yucel, OT, Sungur, A, Onerci, M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 2006;70:227–34
7 Brentani, MM, Butugan, O, Oshima, CTF, Torloni, H, Paiva, LJ. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 1989;99:398401
8 Johns, ME, MacLeod, RM, Cantrell, RW. Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope 1980;90:628–34
9 Lee, DA, Rao, BR, Meyer, JS, Prioleau, PG, Bauer, WC. Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer 1980;46:547–51
10 Hwang, HC, Mills, SE, Patterson, K, Gown, AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 1998;11:1122–6
11 Farag, MM, Ghanimah, SE, Ragaie, A, Saleem, TH. Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope 1987;97:208–11
12 Antonelli, AR, Cappiello, J, Donajo, CA, Di Lorenzo, D, Nicolai, P, Orlandini, A. Diagnosis, staging and treatment of juvenile nasopharyngeal angiofibroma (JNA). Laryngoscope 1987;97:1319–25
13 Gatalica, Z. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett 1998;127:8993
14 Liu, Z, Wang, J, Wang, H, Wang, D, Hu, L, Liu, Q et al. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma. Acta Otolaryngol 2015;135:51–7
15 Montag, AG, Tretiakova, M, Richardson, M. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. Am J Clin Pathol 2006;125:832–7
16 Brieger, J, Wierzbicka, M, Sokolov, M, Roth, Y, Szyfter, W, Mann, WJ. Vessel density, proliferation and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 2004;130:727–31
17 Zhang, M, Sun, X, Yu, H, Hu, L, Wang, D. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem 2011;113:626–30
18 Nonogaki, S, Campos, HG, Butugan, O, Soares, FA, Mangone, FR, Torloni, H et al. Markers of vascular differentiation, proliferation and tissue remodelling in juvenile nasopharyngeal angiofibromas. Exp Ther Med 2010;1:921–6
19 Ponti, G, Losi, L, Pellacani, G, Rossi, GB, Presutti, L, Mattioli, F et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol 2008;16:173–8
20 Schuon, R, Brieger, J, Heinrich, UR, Roth, Y, Szyfter, W, Mann, WJ. Immunohistochemical analysis of growth mechanisms in juvenile angiofibroma. Eur Arch Otorhinolaryngol 2007;264:389–94
21 Schiff, M, Gonzalez, A, Ong, M, Baird, A. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 1992;102:940–5
22 Silveira, SM, Custódio Domingues, MA, Butugan, O, Brentani, MM, Rogatto, SR. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma. Head Neck 2012;34:485–92
23 Nagai, MA, Butugan, O, Logullo, A, Brentani, MM. Expression of growth factors, protooncogenes and p53 in nasopharyngeal angiofibromas. Laryngoscope 1996;106:190–5
24 Schick, B, Wemmert, S, Jung, V, Steuder, W, Montenarh, M, Urbschat, S. Genetic heterogeneity of MYC oncogene in advanced juvenile angiofibromas. Cancer Genet Cytogenet 2006;164:2531
25 Zhang, PJ, Weber, R, Liang, H, Pasha, TL, LiVolsi, VA. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps. Arch Pathol Lab Med 2003;127:1480–4
26 Pauli, J, Gundelach, R, Vanelli-Rees, A, Rees, G, Campbell, C, Dubey, S et al. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 2008;40:396400
27 Dillard, DG, Cohen, C, Muller, S, Del Gaudio, J, Reichman, O, Parrish, B et al. Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 2000;126:723–5
28 Rippel, C, Plinkert, PK, Schick, B. Expression of members of the cadherin-/catenin-protein family in juvenile angiofibromas [in German]. Laryngorhinootologie 2003;82:353–7
29 Abraham, SC, Montgomery, EA, Giardiello, FM, Wu, TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 2001;158:1073–8
30 Schick, B, Veldung, B, Wemmert, S, Jung, V, Montenarh, M, Meese, E et al. p53 and Her-2/neu in juvenile angiofibromas. Oncol Rep 2005;13:453–7
31 Coutinho-Camillo, CM, Brentani, MM, Butugan, O, Torloni, H, Nagai, MA. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas. Diagn Mol Pathol 2003;12:5762
32 Maniglia, MP, Ribeiro, ME, Costa, NM, Jacomini, ML, Carvalho, TB, Molina, FD et al. Molecular pathogenesis of juvenile nasopharyngeal angiofibroma in Brazilian patients. Pediatr Hematol Oncol 2013;30:616–22
33 Gautham, K, Ogale, SB, Shraddha, RU, Ajay, D. Expression of GSTM1 in angiofibromas. J Laryngol Otol 2002;116:352–4
34 Krstulja, M, Car, A, Bonifacić, D, Braut, T, Kujundzić, M. Nasopharyngeal angiofibroma with intracellular accumulation of SPARC – a hypothesis (SPARC in nasopharyngeal angiofibroma). Med Hypotheses 2008;70:600–4
35 Wendler, O, Schäfer, R, Schick, B. Mast cells and T-lymphocytes in juvenile angiofibromas. Eur Arch Otorhinolaryngol 2007;264:769–75
36 Schick, B, Wemmert, S, Bechtel, U, Nicolai, P, Hofmann, T, Golabek, W et al. Comprehensive genomic analysis identifies MDM2 and AURKA as novel amplified genes in juvenile angiofibromas. Head Neck 2007;29:479–87
37 Renkonen, S, Häyry, V, Heikkilä, P, Leivo, I, Haglund, C, Mäkitie, AA et al. Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma – do they have a role? Virchows Arch 2011;458:189–95
38 Coutinho, CM, Bassini, AS, Gutiérrez, LG, Butugan, O, Kowalski, LP, Brentani, MM et al. Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J 1999;117:113–20
39 Renkonen, S, Heikkilä, P, Haglund, C, Mäkitie, AA, Hagström, J. Tenascin-C. GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage. Head Neck 2013;35:1036–42
40 Wang, JJ, Sun, XC, Hu, L, Liu, ZF, Yu, HP, Li, H et al. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance. Head Neck 2013;35:1719–25
41 Duerr, S, Wendler, O, Aigner, T, Karosi, S, Schick, B. Metalloproteinases in juvenile angiofibroma – a collagen rich tumor. Hum Pathol 2008;39:259–68
42 Sun, X, Guo, L, Wang, J, Wang, H, Liu, Z, Liu, J et al. Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis. Int J Pediatr Otorhinolaryngol 2014:78:1232–8
43 Sun, X, Guo, L Wang, H, Yu, H, Wang, J, Meng, X et al. The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor. Am J Otolaryngol 2014:35:582–8
44 Renkonen, S, Cardell, LO, Mattila, P, Lundberg, M, Haglund, C, Hagström, J et al. Toll-like receptors 3, 7, and 9 in juvenile nasopharyngeal angiofibroma. APMIS 2015;123:439–44
45 Schiff, M. Juvenile nasopharyngeal angiofibroma. Laryngoscope 1959;69:9811016.
46 Martin, H, Ehrlich, HE, Abels, JC. Juvenile nasopharyngeal angiofibroma. Ann Surg 1948;127:513–36
47 Johnsen, S, Kloster, JH, Schiff, M. The action of hormones on juvenile nasopharyngeal angiofibroma. Acta Otolaryngol 1966;61:153–60
48 Kumagami, H. Testosterone and estradiol in juvenile nasopharyngeal angiofibroma tissue. Acta Otolaryngol 1991;111:569–73
49 Kumagami, H. Sex hormones in juvenile nasopharyngeal angiofibroma tissue. Auris Nasus Larynx 1993;20:131–5
50 Riggs, S, Orlandi, RR. Juvenile nasopharyngeal angiofibroma recurrence associated with exogenous testosterone therapy. Head Neck 2010;32:812–15
51 Kuttner, K, Katekamp, D, Stiller, D. Hormone therapy of the juvenile angiofibroma. Arch Otorhinolaryngol 1977;214:331–8
52 Arbiser, ZK, Arbiser, JL, Cohen, C, Gal, AA. Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. Mod Pathol 2001;14:1195–9
53 Juric, G, Zarkovic, N, Nola, M, Tillian, M, Jukić, S. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori 2001;87:4753
54 Haggstrom, S, Lissbrant, IF, Bergh, A, Damber, JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 1999;161:1620–5
55 Russell, PJ, Bennett, S, Stricker, P. Growth factor involvement in progression of prostate cancer. Clin Chem 1998;44:705–23
56 Kimbro, KS, Simons, JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006;13:739–49
57 Pelengaris, S, Khan, M, Evan, G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002;2:764–6
58 Liu, J, Levens, D. Making myc. Curr Top Microbiol Immunol 2006;302:132
59 Levens, D. Disentangling the MYC web. Proc Natl Acad Sci U S A 2002;99:5757–9
60 Amir, AL, Barua, M, McKnight, NC, Cheng, S, Yuan, X, Balk, SP. A direct b-catenin independent interaction between androgen receptor and T cell factor. J Biol Chem 2003;278:30828–34
61 Pauli, J, Gundelach, R, Vanelli-Rees, A, Rees, G, Campbell, C, Dubey, S et al. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 2008;40:396400
62 Barbacid, M. Ras genes. Annu Rev Biochem 1987;56:779827
63 Bos, JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682–9
64 Valanzano, R, Curia, MC, Aceto, G, Veschi, S, De Lellis, L, Catalano, T et al. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour. Gut 2005;54:1046–7
65 Klockars, T, Renkonen, S, Leivo, I, Hagström, J, Mäkitie, AA. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis. Fam Cancer 2010;9:401–3
66 Schick, B, Brunner, C, Praetorius, M, Plinkert, PK, Urbschat, S. First evidence of genetic imbalances in angiofibromas. Laryngoscope 2002;112:397401
67 Mohr, LC, Rodgers, JK, Silvestri, GA. Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Res 2003;23:2111–24
68 Smith, MR, Kantoff, PW. Molecular biology of prostate cancer. In: Mendelsohn, AC, Howley, A, Israel, SJ, Liotta, L, eds. The Molecular Basis of Cancer, 2nd edn. Philadelphia: WB Saunders, 2001:723–5


Variable expression of molecular markers in juvenile nasopharyngeal angiofibroma

  • A Mishra (a1), A Pandey (a2) and S C Mishra (a3)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.